Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): Study protocol
- Sebastian R. Hobson*
- , Rebecca Lim
- , Elizabeth E. Gardiner
- , Nicole O. Alers
- , Euan M. Wallace
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
43
Citations
(Scopus)